Similarly, an MS study on prostate cancer demonstrated that differential serum metabolites (L-serine, myoinositol and decanoic acid) performed better than prostate specific antigen in distinguishing patients with prostate cancer from benign prostate hyperplasia (24). The gene discussed is KLK3; the disease is benign prostatic hyperplasia.